Clinical Trial Update: Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov update describes an ongoing Phase 1 study of 19(T2)28z1xx TRAC-CAR T cells in patients with B-cell lymphomas, including diffuse large B-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Diffuse Large B-cell Lymphoma
• High-grade B-cell Lymphoma
• Mediastinal Large B-cell Lymphoma

Drugs mentioned

• TRAC-CAR T Cells (19(T2)28z1xx)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: B-Cell Lymphoma, Large B-cell Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING